
CA 19-9 (monosialoganglioside) isolated from adenocarcinomas of the gastrointestinal tract can be measured in biological fluids using a monoclonal antibody assay. A radioimmunometric assay kit produced by ORIS Industrie has been used to measure the serum level of CA 19-9 in lung cancer and the results have been compared to that of carcinoembryonic antigen. The combination of the 2 markers increase by 10% the number of subjects with a raised marker. There is no significant relationship between the levels of CA 19-9, the type of tumour or the tumour stage. The recognition of the sialic acid as an epitope by the monoclonal antibody appears to be responsible for the false positive results in non-malignant lung disease.
Antigens, Neoplasm, Reference Values, Antigens, Surface, Bronchial Neoplasms, Carcinoma, Radioimmunoassay, Antibodies, Monoclonal, Humans, Antigens, Tumor-Associated, Carbohydrate, Carcinoembryonic Antigen
Antigens, Neoplasm, Reference Values, Antigens, Surface, Bronchial Neoplasms, Carcinoma, Radioimmunoassay, Antibodies, Monoclonal, Humans, Antigens, Tumor-Associated, Carbohydrate, Carcinoembryonic Antigen
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 3 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
